This Drugmaker's Incredible Run Looks Far From Done
Alexion Pharmaceuticals has been a biotech investor's dream stock for years and has created a fortune for patient investors. But with a strong product lineup and healthy pipeline, the future looks great, too.
The 5 Most Expensive Drugs in the World in 2015
These five drugs will set insurers and patients back anywhere from $375,000 per year to as much as $1.21 million per year.